Literature DB >> 19895993

Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.

Franziska Ruëff1, Bernhard Przybilla, Maria Beatrice Biló, Ulrich Müller, Fabian Scheipl, Werner Aberer, Joëlle Birnbaum, Anna Bodzenta-Lukaszyk, Floriano Bonifazi, Christoph Bucher, Paolo Campi, Ulf Darsow, Cornelia Egger, Gabrielle Haeberli, Thomas Hawranek, Michael Körner, Iwona Kucharewicz, Helmut Küchenhoff, Roland Lang, Oliviero Quercia, Norbert Reider, Maurizio Severino, Michael Sticherling, Gunter Johannes Sturm, Brunello Wüthrich.   

Abstract

BACKGROUND: Severe anaphylaxis to honeybee or vespid stings is associated with a variety of risk factors, which are poorly defined.
OBJECTIVE: Our aim was to evaluate the association of baseline serum tryptase concentrations and other variables routinely recorded during patient evaluation with the frequency of past severe anaphylaxis after a field sting.
METHODS: In this observational multicenter study, we enrolled 962 patients with established bee or vespid venom allergy who had a systemic reaction after a field sting. Data were collected on tryptase concentration, age, sex, culprit insect, cardiovascular medication, and the number of preceding minor systemic reactions before the index field sting. A severe reaction was defined as anaphylactic shock, loss of consciousness, or cardiopulmonary arrest. The index sting was defined as the hitherto first, most severe systemic field-sting reaction. Relative rates were calculated with generalized additive models.
RESULTS: Two hundred six (21.4%) patients had a severe anaphylactic reaction after a field sting. The frequency of this event increased significantly with higher tryptase concentrations (nonlinear association). Other factors significantly associated with severe reactions after a field sting were vespid venom allergy, older age, male sex, angiotensin-converting enzyme inhibitor medication, and 1 or more preceding field stings with a less severe systemic reaction.
CONCLUSION: In patients with honeybee or vespid venom allergy, baseline serum tryptase concentrations are associated with the risk for severe anaphylactic reactions. Preventive measures should include substitution of angiotensin-converting enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895993     DOI: 10.1016/j.jaci.2009.08.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  64 in total

1.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

2.  Insect stings: clinical features and management.

Authors:  Bernhard Przybilla; Franziska Ruëff
Journal:  Dtsch Arztebl Int       Date:  2012-03-30       Impact factor: 5.594

3.  Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.

Authors:  W Egner; M Helbert; R Sargur; K Swallow; N Harper; T Garcez; S Savic; L Savic; E Eren
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

Review 4.  Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.

Authors:  Richard Wu; Jonathan J Lyons
Journal:  Curr Allergy Asthma Rep       Date:  2021-05-10       Impact factor: 4.806

Review 5.  [Pharmacoprophylaxis and co-medications in allergen-specific immunotherapy].

Authors:  B Wedi; F Ruëff
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

6.  Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.

Authors:  A Mayado; C Teodosio; A C Garcia-Montero; A Matito; A Rodriguez-Caballero; J M Morgado; C Muñiz; M Jara-Acevedo; I Álvarez-Twose; L Sanchez-Muñoz; S Matarraz; C Caldas; J I Muñoz-González; L Escribano; A Orfao
Journal:  Leukemia       Date:  2015-07-08       Impact factor: 11.528

Review 7.  The Role of KIT Mutations in Anaphylaxis.

Authors:  Elise Coulson; Sherry Zhou; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2019-04-26       Impact factor: 4.806

Review 8.  [Epidemiology of anaphylaxis].

Authors:  M Worm
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

Review 9.  Immunotherapy safety: what have we learned from surveillance surveys?

Authors:  Jennifer A Kannan; Tolly G Epstein
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

10.  [Tricky cases in in-vitro diagnostics of hymenoptera venom allergy].

Authors:  S Müller; D Rafei-Shamsabadi; T Jakob
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.